ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
CytomX Therapeutics
The Director, Process Sciences will lead late-stage process development and commercialization efforts for CytomX's ADC program, overseeing process characterization, analytical control strategies, and BLA readiness. This role involves managing CDMO collaborations, authoring CMC dossiers, and ensuring regulatory compliance while driving cost reductions and supply reliability.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
CytomX Therapeutics is a clinical-stage biopharmaceutical company focused on researching and developing innovative cancer therapies. The company pioneered Probody® therapeutics, a versatile platform designed to unlock the full potential of more potent, less toxic cancer medications, including antibody-drug conjugates (ADCs). CytomX's pipeline includes multiple Probody programs in the clinic, with a lead candidate targeting colon cancer treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CytomX Therapeutics.
9% above the average for this role